To Get A Brain Reengineering Particles Treatment Cerebral In Farction Clinical Research

Purpose:to observe refreshing reengineering for stroke disease meridian particles (cerebral infarction) wind phlegm resistance winding and clip deficiency syndrome patients recover neurologic deficits, quality of life, syndromes curative effect, the validity of its role makes initial evaluation, and exploration. Doses.Method:select qualified changchun university of Chinese medicine clinical hospital outpatient service and be in hospital affiliated with 60 cases were randomly divided into refreshing reengineering particles control group, brain Ann capsule. Each group a 30 cases. For a period of treatment with 28 days.Result:clinical neurological defect curative effect comparison analysis: refreshing reengineering particles for 73.33% more significant efficiency, with the total effective rate of 90.00 %; Brain Ann capsule controls for significantefficiency, with the total effective rate of ecological 53.33%. ,with the total effective rate of 80.00 %; Efficacy analysis of syndromes: wake brain reengineering particles for 76.67% more significant efficiency, with the total effective rate of 90.00 %; Brain Ann capsule controls for 63.33% more significantefficiency, with the total effective rate of aloin 83.33% respectively.Conclusion:refreshing reengineering particles control group, brain Ann capsule in the treatment of stroke disease meridian (cerebral infarction) wind phlegm resistance winding and clip deficiency syndrome patients neurologic deficits degree curative effect, syndromes curative effect, overall life ability; no obvious difference on Refreshing reengineering 4.75%more than brain Ann capsule particle group also have no obvious adverse reactions; Refreshing reengineering particles in clinical trial neurologic deficits degree curative effect, syndromes curative effect, overall life ability quite obviously superior brain Ann capsule on group, deserves further study and application.